ATE447709T1 - Verfahren zum bereitstellen von natürlichen arzneimittel mit hohen therapeutischen indizes - Google Patents
Verfahren zum bereitstellen von natürlichen arzneimittel mit hohen therapeutischen indizesInfo
- Publication number
- ATE447709T1 ATE447709T1 AT03785733T AT03785733T ATE447709T1 AT E447709 T1 ATE447709 T1 AT E447709T1 AT 03785733 T AT03785733 T AT 03785733T AT 03785733 T AT03785733 T AT 03785733T AT E447709 T1 ATE447709 T1 AT E447709T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal products
- high therapeutic
- therapeutic indices
- natural medicinal
- providing natural
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02292787A EP1418428A1 (de) | 2002-11-07 | 2002-11-07 | Verfahren zur Bereitstellung von natürlichen therapeutischen Agenzien mit hohem therapeutischen Index |
US10/315,493 US20040009161A1 (en) | 2002-07-11 | 2002-12-10 | Method for providing natural therapeutic agents with high therapeutic index |
PCT/EP2003/013695 WO2004042394A2 (en) | 2002-11-07 | 2003-11-06 | Method for providing natural therapeutic agents with high therapeutic index |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE447709T1 true ATE447709T1 (de) | 2009-11-15 |
Family
ID=30011282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03785733T ATE447709T1 (de) | 2002-11-07 | 2003-11-06 | Verfahren zum bereitstellen von natürlichen arzneimittel mit hohen therapeutischen indizes |
Country Status (7)
Country | Link |
---|---|
US (2) | US20040009161A1 (de) |
EP (2) | EP1418428A1 (de) |
AT (1) | ATE447709T1 (de) |
AU (1) | AU2003294782A1 (de) |
CA (2) | CA2413981A1 (de) |
DE (1) | DE60329932D1 (de) |
WO (1) | WO2004042394A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2822845B1 (fr) * | 2001-03-30 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques |
US9492111B2 (en) * | 2002-04-22 | 2016-11-15 | Medtronic Minimed, Inc. | Methods and materials for stabilizing analyte sensors |
US7813780B2 (en) * | 2005-12-13 | 2010-10-12 | Medtronic Minimed, Inc. | Biosensors and methods for making and using them |
US20070227907A1 (en) * | 2006-04-04 | 2007-10-04 | Rajiv Shah | Methods and materials for controlling the electrochemistry of analyte sensors |
US9237865B2 (en) * | 2002-10-18 | 2016-01-19 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
US20050272989A1 (en) * | 2004-06-04 | 2005-12-08 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
KR101227779B1 (ko) | 2003-09-18 | 2013-01-29 | 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 | 고성능 에너지 저장 장치 |
AR064292A1 (es) | 2006-12-12 | 2009-03-25 | Commw Scient Ind Res Org | Dispositivo mejorado para almacenamiento de energia |
AR067238A1 (es) | 2007-03-20 | 2009-10-07 | Commw Scient Ind Res Org | Dispositivos optimizados para el almacenamiento de energia |
US9450232B2 (en) | 2009-04-23 | 2016-09-20 | Commonwealth Scientific And Industrial Research Organisation | Process for producing negative plate for lead storage battery, and lead storage battery |
JP5711483B2 (ja) | 2009-08-27 | 2015-04-30 | 古河電池株式会社 | 鉛蓄電池用複合キャパシタ負極板の製造法及び鉛蓄電池 |
CN102725883B (zh) | 2009-08-27 | 2015-08-26 | 联邦科学和工业研究组织 | 电存储装置及其电极 |
JP5797384B2 (ja) | 2009-08-27 | 2015-10-21 | 古河電池株式会社 | 鉛蓄電池用複合キャパシタ負極板及び鉛蓄電池 |
US8660628B2 (en) * | 2009-12-21 | 2014-02-25 | Medtronic Minimed, Inc. | Analyte sensors comprising blended membrane compositions and methods for making and using them |
JP2012133959A (ja) | 2010-12-21 | 2012-07-12 | Furukawa Battery Co Ltd:The | 鉛蓄電池用複合キャパシタ負極板及び鉛蓄電池 |
US9626432B2 (en) | 2013-09-09 | 2017-04-18 | International Business Machines Corporation | Defect record classification |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795976A (en) * | 1995-08-08 | 1998-08-18 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of nucleic acid heteroduplex molecules by denaturing high-performance liquid chromatography and methods for comparative sequencing |
US6020165A (en) * | 1998-11-10 | 2000-02-01 | Incyte Pharmaceuticals, Inc. | Cytikine signal regulators |
FR2822845B1 (fr) * | 2001-03-30 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques |
FR2823764B1 (fr) * | 2001-04-24 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides et polypeptides du gene ifn alpha-17 |
-
2002
- 2002-11-07 EP EP02292787A patent/EP1418428A1/de not_active Withdrawn
- 2002-12-10 US US10/315,493 patent/US20040009161A1/en not_active Abandoned
- 2002-12-11 CA CA002413981A patent/CA2413981A1/en not_active Abandoned
-
2003
- 2003-11-06 AU AU2003294782A patent/AU2003294782A1/en not_active Abandoned
- 2003-11-06 AT AT03785733T patent/ATE447709T1/de not_active IP Right Cessation
- 2003-11-06 WO PCT/EP2003/013695 patent/WO2004042394A2/en not_active Application Discontinuation
- 2003-11-06 EP EP03785733A patent/EP1561105B1/de not_active Expired - Lifetime
- 2003-11-06 US US10/534,098 patent/US20060094641A1/en not_active Abandoned
- 2003-11-06 CA CA002504980A patent/CA2504980A1/en not_active Abandoned
- 2003-11-06 DE DE60329932T patent/DE60329932D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1418428A1 (de) | 2004-05-12 |
CA2413981A1 (en) | 2004-05-07 |
AU2003294782A8 (en) | 2004-06-07 |
EP1561105B1 (de) | 2009-11-04 |
CA2504980A1 (en) | 2004-05-21 |
EP1561105A2 (de) | 2005-08-10 |
WO2004042394A2 (en) | 2004-05-21 |
US20040009161A1 (en) | 2004-01-15 |
AU2003294782A1 (en) | 2004-06-07 |
DE60329932D1 (de) | 2009-12-17 |
US20060094641A1 (en) | 2006-05-04 |
WO2004042394A3 (en) | 2004-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE447709T1 (de) | Verfahren zum bereitstellen von natürlichen arzneimittel mit hohen therapeutischen indizes | |
ATE344029T1 (de) | Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern | |
NO960630L (no) | Heterocykler anvendelige som neurokinin antagonister | |
ATE501711T1 (de) | Verfahren zum entfernen von lösungsmittelrückständen, sowie mit diesem verfahren erhältliche mikropartikel | |
WO2004051223A3 (en) | Method and apparatus for prescribed intensity profile | |
DK1638586T3 (da) | Synergistisk sammensætning til behandling af diabetes mellitus | |
CY1107467T1 (el) | Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων | |
CY1107961T1 (el) | Υλικα οφθαλμικων και ωτορινολαρυγγολογικων συσκευων | |
ATE498395T1 (de) | Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung | |
ATE307593T1 (de) | Mit einem tensid co-mikronisiertes progestin, pharmazeutische zusammensetzung dieses enthaltend,verfahren zu deren herstellung sowie verwendung | |
ATE127342T1 (de) | Verwendung von modafinil zur herstellung eines antiischämischen arzneimittels. | |
DE60310400D1 (de) | Botulinustoxine zur behandlung von priapismus | |
ATE428942T1 (de) | Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen | |
FR2659084B1 (fr) | Composition de caoutchouc, notamment pour chapes de pneus et semelles de chaussures. | |
DE60336068D1 (de) | Antikörper gerichtet gegen oxidierten Apolipoprotein B | |
DE60225579D1 (de) | Photochrome härtbare zusammensetzung mit hohen brechungindex und verfahren zu seiner herstellung | |
DE68904475D1 (de) | Gewisse paf-antagonist/antihistamin-mischungen und verfahren. | |
DE50207732D1 (de) | Kernhydrierte blockcopolymere mit assymetrischem aufbau | |
DE50302673D1 (de) | Substituierte thiophene, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament | |
WO2003104481A3 (en) | PROCESSES | |
ATE389183T1 (de) | Zytokapazität-verfahren | |
ATE433326T1 (de) | Verwendung von löslichem fgl2 als immunosuppressivum | |
ATE416770T1 (de) | Verwendung von vitamin b6 zur verminderung von gesichtsfeldfehlern im zusammenhang mit gaba- ergen medikamenten in säugern | |
ATE357935T1 (de) | Verfahren zum erhöhen der zuführung einer therapeutischen nukleinsäure | |
EP1229423A3 (de) | Verfahren zur Bereitstellung eines geräteindividuellen Gerätecodes für ein elektronisches Gerät |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |